5 active trials 5 recruiting 2 Phase 3 3 disease areas
| Phase 1/2 | 3 | |
| Phase 2/3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT06154252 | RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in… | Idiopathic Inflammatory Myopathy | Recruiting | 2026-09-17 |
| NCT06328777 | RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a… | Systemic Sclerosis | Recruiting | 2026-08-17 |
| Phase 1/2 | ||||
| NCT06121297 | RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201… | Systemic Lupus Erythematosus | Recruiting | 2026-08-26 |
| NCT06359041 | RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With… | Generalized Myasthenia Gravis (gMG) | Recruiting | 2026-08-13 |
| NCT04422912 | A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3… | Pemphigus Vulgaris | Recruiting | 2026-05-29 |
Lupus (SLE) (1) · Myasthenia Gravis (1) · Scleroderma (1)